/* Product view custom css */
API Holdings Limited Unlisted Shares (Pharmeasy)

API Holdings Limited Unlisted Shares (PharmEasy)


API Holdings Limited Unlisted Shares (PharmEasy)

Face Value 1
ISIN No INE0DJ201029

You Can Buy The Below Quantity From Us By Clicking On “Buy Now” Or For More & Bulk Quantity, You Can Contact Us On: 02249369990 / 09867572101 / 09987204585
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
1011332 1 5000 Rs 40.00 Rs 200,000.00 Rs Demat 500
1011330 1 5000 Rs 41.00 Rs 205,000.00 Rs Demat 500

Company Information

API Holdings Limited (PharmEasy) Unlisted Shares

Board of Directors

Co-founder, MD and CEO

: Mr. Siddharth Shah

Chairman and Non-Executive Director

: Mr. Aditya Puri

Co-founder and Whole-time Director

: Mr. Harsh Parekh

Co-Founder and Whole-time Director

: Mr. Dharmil Shah


API Holdings, the parent company of pharmacy platform PharmEasy, is India's largest digital healthcare platform with an integrated, end-to-end business that uses technology and fulfilment capabilities to meet consumers' healthcare needs. The Company has filed DRHP for an IPO with the SEBI to raise Rs 6,250 Crore via fresh equity issuance.

API Holdings owns the "PharmEasy" brand and its proprietary technology powers the PharmEasy marketplace, which is licensed to Axelia Solutions Private Limited to run and operate. The Company has undertaken significant acquisitions like acquisition of Thyrocare and Aknamed in the last two years, through which company aims to consolidate a fragmented market, increase its scale, enhance its capabilities and expand into adjacencies.

Company Highlights

1) Owns 'PharmEasy' brand which is India's largest digital healthcare platform based on gross merchant value (GMV) of products and services sold for the year ended March 31, 2021.

2) Filed DRHP with SEBI on November 10, 2021 to raise Rs. 6250 Crores through IPO and aims to get listed by January or February 2022.

3) Has resilient business model with scale and improving financial metrics.

4) Made significant acquisitions like acquisitions of Thyrocare and Aknamed in the last two years to consolidate a fragmented market and increase its scale and capabilities.

5) The total income jumped more than threefold to Rs 2,360 Crore s in FY2021 from Rs 737 Crores the previous year.

6) Maintained Contribution Margin before sales promotion and marketing expense at 5% like previous year.

Registered Office

902, 9th Floor, Raheja Plaza 1, B-Wing, Opposite R-City Mall, L.B.S. Marg, Ghatkopar West, Mumbai 400 086, Maharashtra, India


: 2019


: www.apiholdings.in


: corporatesecretarial@apiholdings.in


: U60100MH2019PLC323444


: INE0DJ201029


: Healthcare


: 1

Consolidated Financial Information as per DRHP


Rs. (In Crores)

Equity Capital


Face Value


Net Asset Value Per share Rs.


Total Income in FY2021


Loss Per Share in FY2021


Contribution Margin before sales promotion and marketing expense


Pro Forma Financial Statements for FY 2021

API Holding Limited - Balance Sheet

API Holding Limited - Profit & Loss

API Holding Limited - DRHP

Cookie Consent

We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy